| Hydrogels: from controlled release to pH-responsive drug delivery P Gupta, K Vermani, S Garg Drug discovery today 7 (10), 569-579, 2002 | 2241 | 2002 |
| Amorphous drug delivery systems: molecular aspects, design, and performance AM Kaushal, P Gupta, AK Bansal Critical Reviews™ in Therapeutic Drug Carrier Systems 21 (3), 2004 | 347 | 2004 |
| Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective P Gupta, VK Kakumanu, AK Bansal Pharmaceutical research 21, 1762-1769, 2004 | 263 | 2004 |
| Characterization of solid-state forms of celecoxib G Chawla, P Gupta, R Thilagavathi, AK Chakraborti, AK Bansal European Journal of Pharmaceutical Sciences 20 (3), 305-317, 2003 | 206 | 2003 |
| Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility P Gupta, G Chawla, AK Bansal Molecular pharmaceutics 1 (6), 406-413, 2004 | 187 | 2004 |
| Role of molecular interaction in stability of celecoxib− PVP amorphous systems P Gupta, R Thilagavathi, AK Chakraborti, AK Bansal Molecular pharmaceutics 2 (5), 384-391, 2005 | 156 | 2005 |
| Efficient throughput method for hygroscopicity classification of active and inactive pharmaceutical ingredients by water vapor sorption analysis V Murikipudi, P Gupta, V Sihorkar Pharmaceutical development and technology 18 (2), 348-358, 2013 | 80 | 2013 |
| Molecular interactions in celecoxib-PVP-meglumine amorphous system P Gupta, AK Bansal Journal of pharmacy and pharmacology 57 (3), 303-310, 2005 | 74 | 2005 |
| Semisolid dosage forms for dermatological application P Gupta, S Garg Pharm. Technol 26, 144-162, 2002 | 69 | 2002 |
| Improved excipient functionality by coprocessing P Gupta, SK Nachaegari, AK Bansal Excipient development for pharmaceutical, biotechnology, and drug delivery …, 2006 | 65 | 2006 |
| Devitrification of amorphous celecoxib P Gupta, AK Bansal AAPS PharmSciTech 6 (2), 32, 2005 | 54 | 2005 |
| Gastroretentive drug delivery systems G Chawla, P Gupta, AK Bansal Progress in controlled and novel drug delivery systems. CBS Publishers and …, 2004 | 52 | 2004 |
| Spray drying for generation of a ternary amorphous system of celecoxib, PVP, and meglumine P Gupta, AK Bansal Pharmaceutical development and technology 10 (2), 273-281, 2005 | 44 | 2005 |
| Implications of density correction in gravimetric method for water flux determination using rat single-pass intestinal perfusion technique: a technical note C Issa, P Gupta, AK Bansal AAPS PharmSciTech 4 (2), 44, 2003 | 42 | 2003 |
| Ternary amorphous composites of celecoxib, poly (vinyl pyrrolidone) and meglumine with enhanced solubility P Gupta, AK Bansal Die Pharmazie-An International Journal of Pharmaceutical Sciences 60 (11 …, 2005 | 27 | 2005 |
| Gastroretention: A means to address regional variability in intestinal absorption AK Bansal, G Chawla, P Gupta, V Koradia Pharmaceutical technology 2 (1), 50-68, 2003 | 20 | 2003 |
| Differential molecular interactions between the crystalline and the amorphous phases of celecoxib P Gupta, AK Bansal, R Thilagavathi, AK Chakraborti Journal of pharmacy and pharmacology 57 (10), 1271-1278, 2005 | 12 | 2005 |
| Modeling of drug release from celecoxib–PVP–meglumine amorphous systems P Gupta, AK Bansal PDA Journal of Pharmaceutical Science and Technology 59 (6), 346-354, 2005 | 9 | 2005 |
| Nasal dosage forms of dihydroergotamine AN MURTHY, P Gupta, A Jana, VV RATHI, G Karanth, RS Raghuvanshi US Patent App. 16/025,629, 2019 | 6 | 2019 |
| Patent opportunities in matrix-based oral controlled release drug delivery systems, Part II P Gupta, AK Bansal Pharmaceutical Technology Europe 14 (10), 47-56, 2002 | 5 | 2002 |
Arvind BansalProfessor of Pharmaceutics, NIPERDirección de correo verificada de niper.ac.in
